Log in to save to my catalogue

Diltiazem-associated Photodistributed Hyperpigmentation

Diltiazem-associated Photodistributed Hyperpigmentation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7087047

Diltiazem-associated Photodistributed Hyperpigmentation

About this item

Full title

Diltiazem-associated Photodistributed Hyperpigmentation

Publisher

United States: Yale Journal of Biology and Medicine

Journal title

The Yale journal of biology & medicine, 2020-03, Vol.93 (1), p.45-47

Language

English

Formats

Publication information

Publisher

United States: Yale Journal of Biology and Medicine

More information

Scope and Contents

Contents

Diltiazem is a calcium-channel blocker commonly used for the treatment of hypertension. Common adverse effects include dizziness, headache, and edema. Fewer than 20 cases of diltiazem-associated photodistributed hyperpigmentation have been reported in the literature. Here, we present the case of a 71-year-old woman with new-onset facial hyperpigmen...

Alternative Titles

Full title

Diltiazem-associated Photodistributed Hyperpigmentation

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7087047

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7087047

Other Identifiers

ISSN

0044-0086

E-ISSN

1551-4056

How to access this item